Target intelligence / Profile preview

PACRG antisense RNA 3 (PACRG-AS3)

Target
PACRG-AS3
Molecular classification
Antisense long non-coding RNA (lncRNA)
01

Overview

PACRG antisense RNA 3 (PACRG-AS3) is a non-coding antisense long RNA gene located on chromosome 6 (chr6:163165414-163192002, hg38)[3][8]. It does not code for a protein but is thought to play roles in the regulation of its sense counterpart, the PACRG gene, which is involved in pathways relevant to neurodegeneration and immune response, though the precise biological functions and disease relevance of PACRG-AS3 itself remain uncharacterized[1][3][7][8]. No literature currently demonstrates PACRG-AS3 as a direct therapeutic target, nor are there reports of interacting drugs, mechanisms of drug action, or known safety concerns. Its main classification is as an antisense long noncoding RNA.

Other names
PACRG-AS3
02

Mechanism of action

Not applicable; no known drugs or direct mechanism for clinical intervention

03

Biological functions

Regulation of gene expression of the PACRG gene (inferred from the antisense relationship to the PACRG locus)
04

Disease associations

Glioma susceptibility 1 (noted as associated in databases, but no functional/disease mechanism directly established for PACRG-AS3)

Beyond the preview

Go deeper on PACRG antisense RNA 3 (PACRG-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PACRG antisense RNA 3 (PACRG-AS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call